Lightbridge to Hold Business Update & Second Quarter 2022 Earnings Webcast on Thursday, July 28, 2022 at 4pm ET
RESTON, Va., July 21, 2022 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it will release its financial results for the second quarter ended June 30, 2022, more...
Bionano Genomics Announces Publication of a New Study Using OGM to Investigate Chromosome Instability during Culture of Induced Pluripotent Stem Cells
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced publication of a study using optical genome mapping (OGM) to investigate numerical and structural changes to two induced pluripotent stem more...
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. (“Company” or “Apollo”) (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company more...
SigmaTron International, Inc. Reports Amended Credit Agreement With JPMorgan Chase Bank, N.A., and New Term Loan With The Private Credit Group of TCW Asset Management Company LLC, as Agent
ELK GROVE VILLAGE, Ill., July 21, 2022 (GLOBE NEWSWIRE) — SigmaTron International, Inc. (NASDAQ, SGMA), an electronic manufacturing services company (the “Company”), today reported that it amended its existing credit agreement with JPMorgan Chase Bank, more...
Indoor Harvest Binding LOI with Electrum Partners Nears Completion
AUSTIN, July 21, 2022 (GLOBE NEWSWIRE) — Indoor Harvest Corp. (OTCPK: INQD), a publicly traded company focused on the hemp and related industries, is in the final stages of negotiating a binding LOI with Electrum more...
Adamis Pharmaceuticals Issues Letter to Stockholders
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory diseases, issued the following letter to stockholders more...
Arbutus to Report Second Quarter 2022 Financial Results and Provide Corporate Update
WARMINSTER, Pa., July 21, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that it more...
3 Best Breakout Stocks to Invest in for Attractive Returns
Investors generally tend to pick breakout stocks since this strategy promises superlative returns. This method involves zeroing in on those stocks whose prices vary within a narrow band. If the stock price falls below this more...
SARTORIUS (SARTF) Surpasses Q2 Earnings and Revenue Estimates
SARTORIUS (SARTF) came out with quarterly earnings of $2.60 per share, beating the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.43 per share a year ago. These figures are adjusted more...
Lantronix, Inc. (LTRX) Stock Jumps 9.6%: Will It Continue to Soar?
Lantronix, Inc. LTRX shares rallied 9.6% in the last trading session to close at $5.69. This move can be attributable to notable volume with a higher number of shares being traded than in a typical more...